Coming in at over 200 pages, today’s National Academy of Sciences (NAS) report, 'Gene Drives on the Horizon’ is weighty but disappointing. It fails to properly address three of the most pressing issues raised by the controversial new technology of CRISPR-CAS9 gene drives. Dubbed, the ‘mutagenic chain reaction’ by its inventors, RNA-guided gene drives are a high-leverage synthetic biology technology invented only last year.

For a decade, six multinationals have controlled 75% of the world’s high-tech seeds and pesticides businesses. Late last year, Dow and DuPont agreed to merge and now state-owned ChemChina is buying Syngenta for $43 billion. This means that Monsanto needs a merger to stay in the game. Or, is the game about to be called?

The $130 billion Dow-DuPont merger announced last week has rekindled ChemChina’s $44.6 billion bid for Syngenta which, in turn, may provoke a fourth takeover try by Monsanto. If ChemChina prevails, Monsanto is likely to look for a deal with either BASF or Bayer. If they get their way, the world’s Big Six agricultural input companies controlling 75% of global agricultural R&D may be reduced to three or four.

Addis Summit creates a Technology Facilitation Mechanism including a multi-stakeholder forum to discuss technology issues, including risks and opportunities of emerging technologies for the UN’s 2015–30 Sustainable Development Goals.